- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Simcere Pharmaceutical Group Ltd (2096)
Simcere Pharmaceutical Group Ltd stock price live, this page displays HK 2096 stock exchange data. View the 2096 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Simcere Pharmaceutical Group Ltd real time stock price chart below.
What Is the Simcere Pharmaceutical Group Ltd Stock Price Today?
The Simcere Pharmaceutical Group Ltd stock price today is 12.60.
What Is the Stock Symbol for Simcere Pharmaceutical Group Ltd?
The stock symbol for Simcere Pharmaceutical Group Ltd is "2096."
What Stock Exchange Does Simcere Pharmaceutical Group Ltd Trade On?
Simcere Pharmaceutical Group Ltd is listed and trades on the Hong Kong stock exchange.
Is Simcere Pharmaceutical Group Ltd a Good Stock to Buy?
Determining whether Simcere Pharmaceutical Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2096 quote. (ISIN: HK0000658531)
What Is the Simcere Pharmaceutical Group Ltd Stock Price Today?
The Simcere Pharmaceutical Group Ltd stock price today is 12.60.
What Is the Stock Symbol for Simcere Pharmaceutical Group Ltd?
The stock symbol for Simcere Pharmaceutical Group Ltd is "2096."
What Stock Exchange Does Simcere Pharmaceutical Group Ltd Trade On?
Simcere Pharmaceutical Group Ltd is listed and trades on the Hong Kong stock exchange.
Is Simcere Pharmaceutical Group Ltd a Good Stock to Buy?
Determining whether Simcere Pharmaceutical Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2096 quote. (ISIN: HK0000658531)
Hong Kong
Currency in HKD
12.60
-0.29(-2.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.60
12.80
52 wk Range
7.05
15.08
2096 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.6012.80
52 wk Range
7.0515.08
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2096 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
16.77
Upside
+33.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Simcere Pharmaceutical Group Ltd Company Profile
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
Compare 2096 to Peers and Sector
Metrics to compare | 2096 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2096PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.7x | 24.0x | −0.5x | |
PEG Ratio | 0.18 | 0.91 | 0.00 | |
Price/Book | 4.0x | 3.2x | 2.6x | |
Price / LTM Sales | 4.1x | 4.0x | 3.3x | |
Upside (Analyst Target) | 37.2% | 26.2% | 46.0% | |
Fair Value Upside | Unlock | 12.5% | 5.4% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.77
(+33.06% Upside)
Earnings
Latest Release
Sep 29, 2025
EPS / Forecast
0.25 / --
Revenue / Forecast
3.58B / --
People Also Watch
FAQ
What Is the Simcere (2096) Stock Price Today?
The Simcere stock price today is 12.60
What Stock Exchange Does Simcere Trade On?
Simcere is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Simcere?
The stock symbol for Simcere is "2096."
Does Simcere Pay Dividends? What’s The Current Dividend Yield?
The Simcere dividend yield is 1.39%.
What Is the Simcere Market Cap?
As of today, Simcere market cap is 32.57B.
What Is Simcere's Earnings Per Share (TTM)?
The Simcere EPS (TTM) is 0.36.
From a Technical Analysis Perspective, Is 2096 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Simcere Stock Split?
Simcere has split 0 times.
How Many Employees Does Simcere Have?
Simcere has 6815 employees.
What is the current trading status of Simcere (2096)?
As of Feb 18, 2026, Simcere (2096) is trading at a price of 12.60, with a previous close of 12.89. The stock has fluctuated within a day range of 12.60 to 12.80, while its 52-week range spans from 7.05 to 15.08.
What Is Simcere (2096) Price Target According to Analysts?
The average 12-month price target for Simcere is HKD16.77, with a high estimate of HKD19.91968326 and a low estimate of HKD12.57239819. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +33.06% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.